These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Soluble Fas concentrations in the follicular fluid and oocyte-cumulus complex culture medium from women undergoing in vitro fertilization: association with oocyte maturity, fertilization, and embryo quality. Malamitsi-Puchner A, Sarandakou A, Baka S, Vrachnis N, Kouskouni E, Hassiakos D. J Soc Gynecol Investig; 2004 Dec; 11(8):566-9. PubMed ID: 15582503 [Abstract] [Full Text] [Related]
6. Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients. Choi YS, Ku SY, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY, Kim SH. Hum Reprod; 2006 Aug; 21(8):2015-21. PubMed ID: 16601008 [Abstract] [Full Text] [Related]
7. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles. Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY. Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372 [Abstract] [Full Text] [Related]
8. GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles. Pabuccu R, Onalan G, Kaya C. Fertil Steril; 2007 Oct; 88(4):832-9. PubMed ID: 17428479 [Abstract] [Full Text] [Related]
12. The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients. Erdoğan B, Uzaslan E, Budak F, Karadağ M, Ediger D, Oral B, Göral G, Ege E, Gözü O. Tuberk Toraks; 2005 Oct; 53(2):127-31. PubMed ID: 16100648 [Abstract] [Full Text] [Related]
17. Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors. Kondera-Anasz Z, Mielczarek-Palacz A, Sikora J. Apoptosis; 2005 Oct; 10(5):1143-9. PubMed ID: 16151647 [Abstract] [Full Text] [Related]
18. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection. Raghuraman S, Abraham P, Daniel HD, Ramakrishna BS, Sridharan G. J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126 [Abstract] [Full Text] [Related]
19. Comparative study on the pregnancy outcomes of in vitro fertilization-embryo transfer between long-acting gonadotropin-releasing hormone agonist combined with transvaginal ultrasound-guided cyst aspiration and long-acting gonadotropin-releasing hormone agonist alone. Guo YH, Lu N, Zhang Y, Su YC, Wang Y, Zhang YL, Sun YP. Contemp Clin Trials; 2012 Nov; 33(6):1206-10. PubMed ID: 22820320 [Abstract] [Full Text] [Related]
20. Measurement of soluble Fas antigen and ligand in circulating serum and intra-abdominal or cerebrospinal fluid during gastrointestinal or cerebrovascular surgery. Iwama H, Kato M, Ohmori S, Akimaru K, Tsutsumi K, Tohma J, Nakamura N. J Crit Care; 2000 Sep; 15(3):119-25. PubMed ID: 11011825 [Abstract] [Full Text] [Related] Page: [Next] [New Search]